AbbVie
ABBV
#29
Rank
HK$2.864 T
Marketcap
HK$1,620
Share price
-1.03%
Change (1 day)
13.72%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2025 : -HK$25.3 Billion

According to AbbVie's latest financial reports the company has -HK$25.3 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-HK$25.12 Billion-196.17%
2024-12-31$HK$26.11 B-67.84%
2023-12-31$HK$81.20 B-39.88%
2022-12-31$HK$135.06 B12.22%
2021-12-31$HK$120.36 B18.55%
2020-12-31$HK$101.53 B-259.53%
2019-12-31$-HK$63.65 Billion-3.77%
2018-12-31$-HK$66.14 Billion-266.09%
2017-12-31$HK$39.82 B10.77%
2016-12-31$HK$35.95 B17.57%
2015-12-31$HK$30.57 B126.3%
2014-12-31$HK$13.51 B-61.21%
2013-12-31$HK$34.83 B33.63%
2012-12-31$HK$26.06 B-71.87%
2011-12-31$HK$92.67 B-24.16%
2010-12-31$HK$122.20 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$680.00 B-2,788.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$207.94 B-922.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$67.84 B-368.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$143.06 B-665.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$177.24 B-800.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$145.02 B-673.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$381.78 B-1,609.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$168.39 B-765.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$25.49 B-200.78%๐Ÿ‡บ๐Ÿ‡ธ USA